Cyclic (YCDGFYACYMDV)
Cyclic (YCDGFYACYMDV) is a self-assembling peptide inhibitor that targets HER2. It disrupts HER2 dimerization and signaling, inducing apoptosis in cancer cells, with demonstrated efficacy in both in vitro assays and mouse xenograft models for HER2-positive breast cancer research.
Product Specifications
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Molecular Weight
1447.61
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog